Metraipolis › archive › dc_346972143597

In utero Therapy for the Treatment of Sickle Cell Disease: Taking Advantage of the Fetal Immune System — Europe PMC PMID:33553164

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/33553164
DOI
10.3389/fcell.2020.624477
License (as archived)
solo-consultazione
Archived
2026-10-10T01:26:40.988Z
SHA-256 of the archived text
790f6b8dd61bc1ef968346a79c1e5ed1fe0f4cc256baa371842bc77ff85a5bed
Stable URL of this page
https://metraipolis.com/documento/dc_346972143597

How to cite

In utero Therapy for the Treatment of Sickle Cell Disease: Taking Advantage of the Fetal Immune System — Europe PMC PMID:33553164 — Europe PMC (en), https://europepmc.org/article/MED/33553164 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_346972143597 (Metraipolis archive dc_346972143597, sha256 790f6b8dd61bc1ef968346a79c1e5ed1fe0f4cc256baa371842bc77ff85a5bed)
BibTeX
@misc{dc346972143597,
  title = {In utero Therapy for the Treatment of Sickle Cell Disease: Taking Advantage of the Fetal Immune System — Europe PMC PMID:33553164},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/33553164},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_346972143597; sha256 790f6b8dd61bc1ef968346a79c1e5ed1fe0f4cc256baa371842bc77ff85a5bed},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/33553164. Agents can read the archived copy with the MCP tool read_document.